入院患者における高カルセミア:第三級内科病棟における有病率,病因,死亡率の予測要因
Ertunç Şimdi1, Mehmet Uzunlulu2, Erhan Eken2
1Department of Internal Medicine, Istanbul Medeniyet University Göztepe Prof. Dr. Süleyman Yalcin Training and Research Hospital, Istanbul, Türkiye. ertuncsimdi@gmail.com.
Endokrynologia Polska
|February 19, 2026
まとめ
入院患者の高カルセミアは,しばしば悪性腫瘍や高齢と関連しており,高い死亡リスクが伴う. 早期の危険因子の特定と因果特異的な治療は,より良い患者のアウトカムに不可欠です.
科学分野:
- 内科内科は,内科の内科である.
- エンドクリノロジー エンドクリノロジー
- 腫瘍学 腫瘍学
背景:
- ハイパルカルセミアは,入院患者によく見られる深刻な電解質障害です.
- その多様な原因と結果は,患者のケアを改善するために徹底的な理解を必要とします.
研究 の 目的:
- 入院内科患者の高カルセミアの流行,原因,および死亡リスク要因を調査する.
- ハイパルカルセミアとその結果に関連した人口統計,臨床,および研究室の特徴を分析する.
主な方法:
- 2022年1月から2024年1月までの間に,高カルセミア (訂正されたカルシウム≥10.2 mg/dL) で入院した成人患者の遡及的観察コホート研究.
- データ収集には,人口統計,併発症,検査パラメータ,病因,治療法,結果などが含まれていました.
- 死亡リスク要因を特定するために,単変量および多変量分析を使用した.
主要な成果:
- ハイパーカルセミアの罹患率は6% (190/3157人の患者) で,平均年齢は72.3歳でした.
- 主な原因は悪性病 (49.5%) で,次いで他の原因が不明でした.
- 病院での死亡率は24.2%で,男性性,悪性腫瘍,上昇したAST,低アルブミン血症,65~80歳と有意に関連していました.
結論:
- 入院患者の高カルセミアは,悪性腫瘍や高齢化に頻繁に関連しており,高い死亡率に貢献しています.
- 特定の危険因子を特定し,病因学に基づいて管理を調整することは,生存率を改善するために不可欠です.
関連する概念動画
Skeleton and Calcium Homeostasis
6.2K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
6.2K
Synthesis and Functions of Calcitonin
4.8K
Calcitonin, a vital polypeptide hormone, regulates calcium levels within body fluids. It is released by the parafollicular cells, also known as C cells, situated in the follicular epithelium of the thyroid gland. Calcitonin responds to fluctuations in blood calcium levels and the influence of gastrointestinal hormones like gastrin and cholecystokinin.
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
4.8K
Chronic Kidney Disease II: Clinical Manifestations
746
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
746
Chronic Kidney Disease III: Interprofessional Care
500
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
500
Coronary Artery Disease III: Clinical Manifestations
445
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
445
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
458
Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
458

